146 related articles for article (PubMed ID: 30027479)
1. A Single-Dose, Crossover-Design Bioequivalence Study Comparing Two Nicotine Gum Formulations in Healthy Subjects.
Du D
Adv Ther; 2018 Aug; 35(8):1169-1180. PubMed ID: 30027479
[TBL] [Abstract][Full Text] [Related]
2. Single-Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations.
Rasmussen SC; Becker WD; Shanga GM
Clin Pharmacol Drug Dev; 2018 Jun; 7(5):498-505. PubMed ID: 29193747
[TBL] [Abstract][Full Text] [Related]
3. [Improved product characteristics of nicotine gums: an unexplored area for higher compliance with nicotine replacement therapy].
Von Mulzer K; Dando S; Gustavsson G; Radley N; Sjöstedt G; Sydbom P; Waltermo A
MMW Fortschr Med; 2011 Oct; 153 Suppl 3():75-82. PubMed ID: 22184800
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
.
Sukhija M; Srivastava R; Kaushik A
Int J Clin Pharmacol Ther; 2018 Mar; 56(3):113-119. PubMed ID: 29350176
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Characterization of a Prototype Mini Nicotine Lozenge.
Lai PM; Araga M; Hamilton A; Armogida M
Adv Ther; 2021 Jul; 38(7):3997-4012. PubMed ID: 34105089
[TBL] [Abstract][Full Text] [Related]
6. The bioequivalent and effect of nicotine formulation gum on smoking cessation.
Tundulawessa Y; Yongchaiyud P; Chutrthong W; Tundulawessa K
J Med Assoc Thai; 2010 May; 93(5):574-9. PubMed ID: 20524443
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of a nicotine polacrilex lozenge.
Choi JH; Dresler CM; Norton MR; Strahs KR
Nicotine Tob Res; 2003 Oct; 5(5):635-44. PubMed ID: 14577980
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic investigation of a nicotine sublingual tablet.
Molander L; Lunell E
Eur J Clin Pharmacol; 2001; 56(11):813-9. PubMed ID: 11294371
[TBL] [Abstract][Full Text] [Related]
9. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
10. Can we increase smokers' adherence to nicotine replacement therapy and does this help them quit?
Schlam TR; Cook JW; Baker TB; Hayes-Birchler T; Bolt DM; Smith SS; Fiore MC; Piper ME
Psychopharmacology (Berl); 2018 Jul; 235(7):2065-2075. PubMed ID: 29696311
[TBL] [Abstract][Full Text] [Related]
11. Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy.
Kraiczi H; Hansson A; Perfekt R
Nicotine Tob Res; 2011 Dec; 13(12):1176-82. PubMed ID: 21849415
[TBL] [Abstract][Full Text] [Related]
12. Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers.
Caldwell B; Burgess C; Crane J
Nicotine Tob Res; 2010 Feb; 12(2):179-83. PubMed ID: 20064899
[TBL] [Abstract][Full Text] [Related]
13. Nicotine replacement therapy for smoking cessation.
Stead LF; Perera R; Bullen C; Mant D; Lancaster T
Cochrane Database Syst Rev; 2008 Jan; (1):CD000146. PubMed ID: 18253970
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers.
Rasmussen S; Horkan KH; Kotler M
Clin Pharmacol Drug Dev; 2018 Jun; 7(5):506-512. PubMed ID: 29394003
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.
Liu J; Wang J; Vansickel A; Edmiston J; Graff D; Sarkar M
Clin Pharmacol Drug Dev; 2021 Mar; 10(3):241-250. PubMed ID: 33502815
[TBL] [Abstract][Full Text] [Related]
16. In vivo bioequivalence of oral antidiabetic agents: pioglitazone tablets.
Wong H; Ozalp Y; Lainesse A; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):618-24. PubMed ID: 15497670
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell).
Dautzenberg B; Nides M; Kienzler JL; Callens A
BMC Clin Pharmacol; 2007 Oct; 7():11. PubMed ID: 17922899
[TBL] [Abstract][Full Text] [Related]
18. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
[TBL] [Abstract][Full Text] [Related]
19. Nicotine replacement therapy for smoking cessation.
Silagy C; Lancaster T; Stead L; Mant D; Fowler G
Cochrane Database Syst Rev; 2001; (3):CD000146. PubMed ID: 11686953
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three nicotine treatments: initial reactions and preferences with guided use.
Schneider NG; Terrace S; Koury MA; Patel S; Vaghaiwalla B; Pendergrass R; Olmstead RE; Cortner C
Psychopharmacology (Berl); 2005 Nov; 182(4):545-50. PubMed ID: 16133134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
